-
Early age at menopause and first childbirth associated with increased risk of lung cancer: Study
28 Mar 2024 19:54 GMT
… distinguish lung cancer in women from that in men, with adenocarcinoma being … an elevated risk of lung cancer, particularly of lung adenocarcinoma (LUAD), in … Liu H, genetic risk, lung cancer, menopause, non-small cell lung cancer, reproductive factors
-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… with metastatic lung cancer, lung cancer continues to … cycles.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … junction (GEJ) adenocarcinoma.
Esophageal Cancer
KEYTRUDA …
-
Effects of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Cancer Induced Bone Pain Relief in Patients with Non-Small Cell Lung Cancer: Study Protocol for a Randomized Controlled Trial
26 Mar 2024 10:51 GMT
… small cell lung cancer (stage I–IV), including adenocarcinoma, squamous … with pain unrelated to lung cancer. ② Patients who received … in non-small cell lung cancer (NSCLC): microenvironment and … Youth Specialists Committee of Lung Cancer, Beijing Medical Award …
-
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
25 Mar 2024 10:25 GMT
… and 26 patients had adenocarcinoma and squamous cell carcinoma, … with non-small-cell lung cancer. Clin Lung Cancer. 2021;22(1): … non-small-cell lung cancer patients. Clin Lung Cancer. 2020;21(5 … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2015;4 …
-
A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report
26 Mar 2024 20:33 GMT
… small-cell lung cancer (NSCLC) accounts for approximately 80% of lung cancers and … with lung tumors indicated with red arrows.
Abbreviations: LUAD, lung adenocarcinoma; NGS … aspiration biopsy specimen showed lung adenocarcinoma (10×).
Subsequent targeted NGS …
-
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights
29 Mar 2024 08:00 GMT
… metastatic squamous non-small cell lung cancer ("sq NSCLC") was … unresectable or metastatic pancreatic ductal adenocarcinoma without systemic treatment, was recommended …
-
[Latest] Global Cancer Immunotherapy Market Size/Share Worth USD 314.4 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
28 Mar 2024 19:30 GMT
… Squamous Cell Carcinoma, Melanoma, Adenocarcinoma, Basal Cell Carcinoma), By … and Forecast 2024–2033 Lung Cancer Surgery Market: Lung Cancer Surgery Market Size, … By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management …
-
The Genetic Basis of Cancer
28 Mar 2024 17:22 GMT
… smoking
radiation and
and lung cancer
skin cancer
Three main … 33
Tobacco smoking and lung cancer
Human papilloma virus (HPV … non-small cell lung cancers (30%)
pancreatic ductal adenocarcinomas (up to … 33
Tobacco smoking and lung cancer
Human papilloma virus (HPV …
-
The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer
28 Mar 2024 13:57 GMT
… non-small cell lung cancer,18 oral,28 … , Cholangiocarcinoma; COAD, Colon adenocarcinoma; CTD, Comparative Toxicogenomics Database … serous cystadenocarcinoma; PAAD, Pancreatic adenocarcinoma; pCR, Pathological complete … in non-small-cell lung cancer. PLoS One. …
-
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
28 Mar 2024 12:05 GMT
… for non-small cell lung cancer and borderline resectable pancreatic … and biomarker data in lung cancer, pancreatic cancer, and … patients with pancreatic ductal adenocarcinoma to improve overall survival … trials in non-small cell lung cancer (NSCLC) (phase 2), …